USPTO serial 97492223
LIPIDRESCUE
Reviewed by CopyMark Law Group
Status 734Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAHONEY, KATHERINE AILEEN
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with LIPIDRESCUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $250
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chicago, IL, US
Chicago, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Hillary Maynard
Hillary Maynard POLSINELLI PC150 NORTH RIVERSIDE PLAZASUITE 3000CHICAGO, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating anesthetic and drug toxicity; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in resuscitating patients; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardiac arrest due to ischemia, treating cardiac failure, treating cardiac toxicity, and for resuscitating patients | ACTIVE | — |
| 044 | Medical services, namely, treating anesthetic toxicity, treating drug overdoses and poisoning, resuscitating patients suffering from the toxic side effects caused by anesthetics and unknown substances, treating cardiac toxins, administering lipid emulsions and other lipid containing substances to patients, and administering lipid emulsions to treat cardiac arrest due to ischemia, cardiac failure, and cardiac toxicity | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 18, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 18, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 17, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 29, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 28, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 5, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 5, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 18, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 17, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 17, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 17, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 17, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 17, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 17, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 17, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 23, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 22, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 22, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 22, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 24, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 29, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 29, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 9, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 26, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 26, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 26, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 26, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 20, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 19, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 11, 2022 | NWAP | NEW APPLICATION ENTERED | — |